Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5998
+0.0201 (3.47%)
At close: Sep 2, 2025, 4:00 PM
0.5998
0.00 (0.00%)
After-hours: Sep 2, 2025, 6:30 PM EDT

Impact BioMedical Statistics

Total Valuation

IBO has a market cap or net worth of $7.31 million. The enterprise value is $28.93 million.

Market Cap7.31M
Enterprise Value 28.93M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

IBO has 12.19 million shares outstanding. The number of shares has decreased by -60.60% in one year.

Current Share Class 12.19M
Shares Outstanding 12.19M
Shares Change (YoY) -60.60%
Shares Change (QoQ) +1.02%
Owned by Insiders (%) 0.79%
Owned by Institutions (%) 4.17%
Float 11.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,028.80
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4,132.80
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.77

Financial Efficiency

Return on equity (ROE) is -405.44% and return on invested capital (ROIC) is -9.50%.

Return on Equity (ROE) -405.44%
Return on Assets (ROA) -8.24%
Return on Invested Capital (ROIC) -9.50%
Return on Capital Employed (ROCE) 101.31%
Revenue Per Employee $3,500
Profits Per Employee -$19.24M
Employee Count2
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, IBO has paid $33,000 in taxes.

Income Tax 33,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 0.66
200-Day Moving Average 1.21
Relative Strength Index (RSI) 50.04
Average Volume (20 Days) 290,905

Short Selling Information

The latest short interest is 213,029, so 1.75% of the outstanding shares have been sold short.

Short Interest 213,029
Short Previous Month 308,219
Short % of Shares Out 1.75%
Short % of Float 1.81%
Short Ratio (days to cover) 0.61

Income Statement

In the last 12 months, IBO had revenue of $7,000 and -$38.47 million in losses. Loss per share was -$3.26.

Revenue7,000
Gross Profit -4,000
Operating Income -4.17M
Pretax Income -8.34M
Net Income -38.47M
EBITDA -4.16M
EBIT -4.17M
Loss Per Share -$3.26
Full Income Statement

Balance Sheet

The company has $624,000 in cash and $22.35 million in debt, giving a net cash position of -$21.73 million or -$1.78 per share.

Cash & Cash Equivalents 624,000
Total Debt 22.35M
Net Cash -21.73M
Net Cash Per Share -$1.78
Equity (Book Value) -7.38M
Book Value Per Share -0.85
Working Capital -21.69M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.43M
Capital Expenditures n/a
Free Cash Flow -4.43M
FCF Per Share -$0.36
Full Cash Flow Statement

Margins

Gross Margin -57.14%
Operating Margin -59,514.29%
Pretax Margin -549,828.57%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IBO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 60.60%
Shareholder Yield 60.60%
Earnings Yield -534.23%
FCF Yield -61.49%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IBO has an Altman Z-Score of -5.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.6
Piotroski F-Score 2